135 related articles for article (PubMed ID: 10528990)
1. Inhibitory effects of the antihistamines epinastine, terfenadine, and ebastine on potassium currents in rat ventricular myocytes.
Ohtani H; Hanada E; Hirota M; Sato H; Kotaki H; Sawada Y; Uemura H; Nakaya H; Iga T
J Pharm Pharmacol; 1999 Sep; 51(9):1059-63. PubMed ID: 10528990
[TBL] [Abstract][Full Text] [Related]
2. A comparison of Cetirizine, Ebastine, Epinastine, Fexofenadine, Terfenadine, and Loratadine versus placebo in suppressing the cutaneous response to histamine.
Grant JA; Danielson L; Rihoux J; DeVos C
Int Arch Allergy Immunol; 1999; 118(2-4):339-40. PubMed ID: 10224437
[No Abstract] [Full Text] [Related]
3. Comparative effects of nonsedating histamine H1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channels.
Valenzuela C; Delpón E; Franqueza L; Gay P; Vicente J; Tamargo J
Eur J Pharmacol; 1997 May; 326(2-3):257-63. PubMed ID: 9196279
[TBL] [Abstract][Full Text] [Related]
4. Suppression of mammalian K+ channel family by ebastine.
Ko CM; Ducic I; Fan J; Shuba YM; Morad M
J Pharmacol Exp Ther; 1997 Apr; 281(1):233-44. PubMed ID: 9103502
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of loratadine and terfenadine on cardiac K+ channels.
Ducic I; Ko CM; Shuba Y; Morad M
J Cardiovasc Pharmacol; 1997 Jul; 30(1):42-54. PubMed ID: 9268220
[TBL] [Abstract][Full Text] [Related]
6. Epinastine, a nonsedating histamine H1 receptor antagonist, has a negligible effect on HERG channel.
Chachin M; Katayama Y; Yamada M; Horio Y; Ohmura T; Kitagawa H; Uchida S; Kurachi Y
Eur J Pharmacol; 1999 Jun; 374(3):457-60. PubMed ID: 10422790
[TBL] [Abstract][Full Text] [Related]
7. Regulation of potassium channels by nonsedating antihistamines.
Berul CI; Morad M
Circulation; 1995 Apr; 91(8):2220-5. PubMed ID: 7697852
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological study of ebastine, a novel histamine H1-receptor antagonist].
Yakuo I; Ishii K; Seto Y; Imano K; Takeyama K; Nakamura H; Karasawa T
Nihon Yakurigaku Zasshi; 1994 Mar; 103(3):121-35. PubMed ID: 7511558
[TBL] [Abstract][Full Text] [Related]
9. A comparative pharmacokinetic-pharmacodynamic study of the electrocardiographic effects of epinastine and terfenadine in rats.
Ohtani H; Kotaki H; Sawada Y; Iga T
J Pharm Pharmacol; 1997 Apr; 49(4):458-62. PubMed ID: 9232548
[TBL] [Abstract][Full Text] [Related]
10. Effects of histamine H1 receptor antagonists on action potentials in guinea-pig isolated papillary muscles.
Ki I; Inui A; Ito T
Arch Int Pharmacodyn Ther; 1996; 331(1):59-73. PubMed ID: 8896711
[TBL] [Abstract][Full Text] [Related]
11. Towards the optimal antihistamine: studies with ebastine.
Roberts DJ
Inflamm Res; 1998; 47 Suppl 1():S36-7. PubMed ID: 9561405
[No Abstract] [Full Text] [Related]
12. Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval.
Malik M
Br J Clin Pharmacol; 2002 Dec; 54(6):682-3. PubMed ID: 12492623
[No Abstract] [Full Text] [Related]
13. [The effect of second generation histamine antagonists on the heart].
Grzelewska-Rzymowska I; Pietrzkowicz M; Górska M
Pneumonol Alergol Pol; 2001; 69(3-4):217-26. PubMed ID: 11575008
[TBL] [Abstract][Full Text] [Related]
14. Effects of terfenadine, astemizole and epinastine on electrocardiogram in conscious cynomolgus monkeys.
Ohmura T; Chachin M; Tarui S; Nagakura A; Igarashi T; Ikeda H; Ikegami K; Kitagawa H; Uchida S
Eur J Pharmacol; 1999 Aug; 378(2):169-75. PubMed ID: 10478629
[TBL] [Abstract][Full Text] [Related]
15. Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale.
Izumi N; Mizuguchi H; Umehara H; Ogino S; Fukui H
Methods Find Exp Clin Pharmacol; 2008 Apr; 30(3):225-30. PubMed ID: 18597008
[TBL] [Abstract][Full Text] [Related]
16. Preclinical comparison of ebastine and other second generation H1-antihistamines.
Yakuo I; Yabuuchi M; Ito T
Pharmacol Toxicol; 2001 Oct; 89(4):171-6. PubMed ID: 11881966
[TBL] [Abstract][Full Text] [Related]
17. Blockade of HERG and Kv1.5 by ketoconazole.
Dumaine R; Roy ML; Brown AM
J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
[TBL] [Abstract][Full Text] [Related]
18. Antihistaminic activity and side effect profile of epinastine and terfenadine in healthy volunteers.
Schilling JC; Adamus WS; Kuthan H
Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):493-7. PubMed ID: 1982280
[TBL] [Abstract][Full Text] [Related]
19. Blockage by terfenadine of the adenosine triphosphate (ATP)-sensitive K+ current in rabbit ventricular myocytes.
Nishio M; Habuchi Y; Tanaka H; Morikawa J; Yamamoto T; Kashima K
J Pharmacol Exp Ther; 1998 Oct; 287(1):293-300. PubMed ID: 9765349
[TBL] [Abstract][Full Text] [Related]
20. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine.
Roy M; Dumaine R; Brown AM
Circulation; 1996 Aug; 94(4):817-23. PubMed ID: 8772706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
